Merck (MRK) FCF Payout Ratio (2009 - 2026)
Merck (MRK) reported FCF Payout Ratio of 0.72 for Q1 2026, down 58.88% year-over-year from 1.75 in Q1 2025, and down 35.0% on a QoQ basis from 1.11 in Q4 2025.
Merck (MRK) has 18 years of FCF Payout Ratio data on file, last reported at 0.72 in Q1 2026.
- Quarterly FCF Payout Ratio fell 58.88% year-over-year to 0.72 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.58 (up 25.14% YoY) and the FY2025 annual result came in at 0.66, up 52.68% from the prior year.
- FCF Payout Ratio declined to 0.72 in Q1 2026 per MRK's latest filing, from 1.11 in the prior quarter.
- Across five years, FCF Payout Ratio topped out at 5.58 in Q1 2023 and bottomed at 2.49 in Q4 2023.
- The 5-year median for FCF Payout Ratio is 0.56 (2022), against an average of 0.76.
- Peak annual rise in FCF Payout Ratio reached 1108.06% in 2023, while the deepest fall reached 567.33% in 2023.
- Tracing MRK's FCF Payout Ratio over 5 years: stood at 0.53 in 2022, then plunged by 567.33% to 2.49 in 2023, then jumped by 131.15% to 0.78 in 2024, then jumped by 42.51% to 1.11 in 2025, then slumped by 35.0% to 0.72 in 2026.
- Per Business Quant, the three latest MRK FCF Payout Ratio figures stand at 0.72 (Q1 2026), 1.11 (Q4 2025), and 0.3 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 0.51 |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 2.14 |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 0.87 |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 0.72 |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 0.92 |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 0.43 |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 1.12 |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 1.69 |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.72 |
| Dec 31, 2025 | 1.11 |
| Sep 30, 2025 | 0.30 |
| Jun 30, 2025 | 0.82 |
| Mar 31, 2025 | 1.75 |
| Dec 31, 2024 | 0.78 |
| Sep 30, 2024 | 0.23 |
| Jun 30, 2024 | 0.41 |
| Mar 31, 2024 | 0.87 |
| Dec 31, 2023 | -2.49 |
| Sep 30, 2023 | 0.27 |
| Jun 30, 2023 | 0.69 |
| Mar 31, 2023 | 5.58 |
| Dec 31, 2022 | 0.53 |
| Sep 30, 2022 | 0.39 |
| Jun 30, 2022 | 0.56 |
| Mar 31, 2022 | 0.46 |
| Dec 31, 2021 | 0.42 |
| Sep 30, 2021 | 0.45 |
| Jun 30, 2021 | 1.67 |
| Mar 31, 2021 | 10.41 |
| Dec 31, 2020 | 0.78 |
| Sep 30, 2020 | 1.21 |
| Jun 30, 2020 | 1.17 |
| Mar 31, 2020 | -5.56 |
| Dec 31, 2019 | -1.77 |
| Sep 30, 2019 | 0.43 |
| Jun 30, 2019 | 0.64 |
| Mar 31, 2019 | 1.93 |
| Dec 31, 2018 | 0.48 |
| Sep 30, 2018 | 0.60 |
| Jun 30, 2018 | 0.47 |
| Mar 31, 2018 | 1.84 |
| Dec 31, 2017 | 0.39 |
| Sep 30, 2017 | -0.80 |
| Jun 30, 2017 | 0.45 |
| Mar 31, 2017 | -24.42 |
| Dec 31, 2016 | 0.41 |
| Sep 30, 2016 | 0.50 |
| Jun 30, 2016 | 1.06 |
| Mar 31, 2016 | 0.68 |
| Dec 31, 2015 | 0.34 |
| Sep 30, 2015 | 0.42 |
| Jun 30, 2015 | 0.54 |
| Mar 31, 2015 | 0.62 |
| Dec 31, 2014 | -0.83 |
| Sep 30, 2014 | 0.32 |
| Jun 30, 2014 | 0.67 |
| Mar 31, 2014 | 0.60 |
| Dec 31, 2013 | 0.49 |
| Sep 30, 2013 | 0.35 |
| Jun 30, 2013 | 0.69 |
| Mar 31, 2013 | 0.66 |
| Dec 31, 2012 | -3.60 |
| Sep 30, 2012 | 0.47 |
| Jun 30, 2012 | 0.51 |
| Mar 31, 2012 | 0.70 |
| Dec 31, 2011 | -1.30 |
| Sep 30, 2011 | 0.28 |
| Jun 30, 2011 | 0.47 |
| Mar 31, 2011 | 0.84 |
| Dec 31, 2010 | -1.19 |
| Sep 30, 2010 | 0.52 |
| Jun 30, 2010 | 0.40 |
| Mar 31, 2010 | 1.16 |
| Dec 31, 2009 | 0.48 |
| Sep 30, 2009 | -1.31 |
| Jun 30, 2009 | 2.09 |
| Mar 31, 2009 | 1.68 |